Schroder Investment Management Group’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-96,914	Closed	-$1.97M	–	1267
2022 Q4	$1.97M	Sell	96,914 -12,036	-11%	-$302K	﹤0.01%	945
2022 Q3	$2.79M	Sell	108,950 -52,572	-33%	-$1.41M	﹤0.01%	884
2022 Q2	$4M	Buy	161,522 +30,588	+23%	+$666K	0.01%	835
2022 Q1	$3.17M	Sell	130,934 -7,585	-5%	-$161K	﹤0.01%	936
2021 Q4	$2.74M	Sell	138,519 -4,990	-3%	-$101K	﹤0.01%	871
2021 Q3	$2.82M	Sell	143,509 -12,008	-8%	-$251K	﹤0.01%	909
2021 Q2	$3.42M	Buy	155,517 +35,217	+29%	+$784K	﹤0.01%	905
2021 Q1	$2.86M	Sell	120,300 -139,622	-54%	-$3.73M	﹤0.01%	941
2020 Q4	$6.8M	Buy	259,922 +92,176	+55%	+$1.94M	0.01%	733
2020 Q3	$2.84M	Sell	167,746 -9,133	-5%	-$146K	﹤0.01%	834
2020 Q2	$2.98M	Sell	176,879 -28,348	-14%	-$398K	0.01%	755
2020 Q1	$2.37M	Buy	205,227 +187,365	+1,049%	+$2.32M	0.01%	775
2019 Q4	$216K	Buy	17,862 +1,409	+9%	+$19.6K	﹤0.01%	1155
2019 Q3	$240K	Buy	+16,453	New	+$202K	﹤0.01%	1137
2018 Q3	–	Sell	-29,680	Closed	-$469K	–	1288
2018 Q2	$469K	Buy	29,680 +527	+2%	+$9.17K	﹤0.01%	1047
2018 Q1	$480K	Buy	29,153 +1,665	+6%	+$30.9K	﹤0.01%	1063
2017 Q4	$496K	Buy	27,488 +4,688	+21%	+$84.9K	﹤0.01%	1096
2017 Q3	$432K	Hold	22,800	–	–	﹤0.01%	1097
2017 Q2	$272K	Buy	+22,800	New	+$248K	﹤0.01%	1131